U.S. Stem Cell, Inc.
USRM
$0.0001
$0.000.00%
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -2.86M | -2.93M | -3.04M | -3.46M | -3.29M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.27M | 2.19M | 2.24M | 2.35M | 2.20M |
| Change in Net Operating Assets | 285.20K | 259.50K | 179.60K | 312.00K | 28.10K |
| Cash from Operations | -304.90K | -478.50K | -619.80K | -804.20K | -1.06M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 213.20K | 210.70K | 234.70K | 134.00K | 856.00K |
| Total Debt Repaid | -27.60K | -42.30K | -52.40K | -59.30K | -52.10K |
| Issuance of Common Stock | 85.00K | 310.00K | 310.00K | 300.00K | 275.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 270.60K | 478.40K | 492.30K | 374.70K | 1.08M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -34.20K | -100.00 | -127.50K | -429.50K | 20.90K |
